MAPT and early-onset autosomal dominant Alzheimer disease: We selected the BIONi010‐C‐2 (APOE3/3) cell line to detect early changes in Alzheimer's disease (AD) pathology markers, such as amyloid beta or tau aggregation, upon exposure of the matured organoids to increased norepinephrine (NE).